Human Preferentially Expressed Antigen In Melanoma (PRAME) ELISA Kit

PRAME (Preferentially Expressed Antigen in Melanoma) is a cancer-testis antigen that shows restricted expression in normal tissues but is reactivated in melanoma and other solid and hematologic malignancies, making it a focal target in tumor immunology research, cancer vaccine development, and immunotherapy monitoring. This Assay Genie ELISA kit provides quantitative measurement of human PRAME protein in tissue homogenates, cell lysates, and cell culture supernatants through a colorimetric plate-based assay run in 96 assays format. The kit is configured for in vitro research use only and supports studies of antigen presentation, T-cell recognition, and tumor-associated immune responses in patient samples and cell models. Each kit ships with the reagents required to generate a standard curve and process samples in a standard microplate workflow. Investigators working on melanoma progression, adoptive cell therapy targets, or biomarker discovery will find the assay useful for profiling PRAME expression across experimental conditions and treatment cohorts.